Evaluate TCRT-ESO-A2 Autologous T Cells Expressing TCR Specific for NY-ESO-1 in Subjects With Advanced Solid Tumors
NCT04878484
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Poor recruitment
Conditions
Advanced Solid Tumor
Interventions
BIOLOGICAL:
TCRT-ESO-A2
Sponsor
Athenex, Inc.